| NCT ID | NCT07054944 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Rochester |
| Condition | Pediatric Solid Tumors |
| Study Type | OBSERVATIONAL |
| Enrollment | 10 participants |
| Start Date | 2026-04-13 |
| Primary Completion | 2028-07-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 10 participants in total. It began in 2026-04-13 with a primary completion date of 2028-07-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to assess the feasibility and safety of ICG-guided intraoperative lymphography for detecting sentinel lymph nodes (SLN) in pediatric patients with solid tumors who require retroperitoneal lymph node dissection/sampling. This trial is a single-site cross-sectional study. The injection of ICG directly into lymphatics draining the primary tumor will take place at the time of operation after the patient is under anesthesia.
Eligibility Criteria
Inclusion Criteria: * Any pediatric patient (under the age of 18 years) being treated at the University of Rochester Medical Center, Department of Surgery. * Diagnosed with pediatric solid tumor * Scheduled to undergo lymph node sampling as part of their clinical management. Exclusion Criteria: * Subjects with a history of iodide allergies. * Inability or unwillingness of research participant or parent/legal guardian to give written informed consent. * Currently pregnant. * Infants under 650 grams. * Patients with extensive prior surgery at the primary site or nodal basin expected to affect the lymphatic drainage.
Contact & Investigator
Abdelhafeez Abdelhafeez, MD
✉ Abdelhafeez_Abdelhafeez@URMC.Rochester.eduFrequently Asked Questions
Who can join the NCT07054944 clinical trial?
This trial is open to participants of all sexes, aged 1 Month or older, up to 17 Years, studying Pediatric Solid Tumors. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07054944 currently recruiting?
Yes, NCT07054944 is actively recruiting participants. Contact the research team at Abdelhafeez_Abdelhafeez@URMC.Rochester.edu for enrollment information.
Where is the NCT07054944 trial being conducted?
This trial is being conducted at Rochester, United States.
Who is sponsoring the NCT07054944 clinical trial?
NCT07054944 is sponsored by University of Rochester. The trial plans to enroll 10 participants.